Our co-founders

Patti’s only daughter Tina was diagnosed with Inflammatory Breast Cancer in 2003, which had already metastasized to her liver. Tina pleaded with her mother to write about this under reported and overly misdiagnosed type of breast cancer. Not finding anyone who was willing to take her writings, (for fear of scaring the public), she turned to television. When she met the staff KOMO TV in Seattle Washington, she found a physical voice and a way to get the message to the masses.

On August 29, 2007 Patti lost her beloved daughter, Kristine “Tina” Turck.

“Knowledge is Power” says Patti, is the only way we can win this war” The battle of education in the public arena as well as the medical community is not over, and will not be until not one more woman is ‘surprised’ by a diagnosis of Inflammatory Breast Cancer.

Director of the OncoSET Precision Medicine Program

Department of Medicine-Hematology and Oncology

Robert H Lurie Comprehensive Cancer Center at Northwestern University

I am a physician-scientist known for contributions in several areas of clinical and translational research—one of which is the research and treatment of inflammatory breast cancer (IBC), the most aggressive and deadly form of breast cancer.

I have worked for many years in defining the unique biological and clinical aspects of IBC. I started in the Morgan Welch IBC Research Program and Clinic, the first of its kind solely dedicated to this disease. The International Collaboration in IBC research has creased with the creation of the IBC International Consortium (IBC-IC) with IBC International Conferences held every two years. These events contribute to increased awareness and understanding of the disease and the development of dedicated clinical trials to improve the outcome for these patients.

• Advanced Molecular Diagnostics
• Breast Cancer
• Endocrine Resistance
• Inflammatory Breast Cancer
• Metastatic Breast Cancer